Novo Integrated Sciences, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Oliva Robert Letterio, was filed 21 Apr 2022.
Novo Integrated Sciences, Inc.: what insiders have been doing
Every trade that managers of Novo Integrated Sciences, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Novo Integrated Sciences, Inc. The previous disclosure was published on 21 April 2022.
The full history, which starts in 2006, counts 11 purchases against 36 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- -95.1%Entry US$22.00 · Close at T+365 US$1.07
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended August 2023 · cache
- 4,700 shares@ US$2.230.0% of flowCommon StockSEC:0001493152-22-010621:1Canonical exit: 19 Jul 2022 (T+90)
- 300 shares@ US$2.250.0% of flowCommon StockSEC:0001493152-22-010621:2Canonical exit: 19 Jul 2022 (T+90)
- 5,000 shares@ US$2.225100.0% of flowCommon StockSEC:0001493152-22-010621:0Canonical exit: 18 Jul 2022 (T+90)
- 13,000 shares@ US$2.12Common StockSEC:0001493152-21-009571:0Canonical exit: 20 Jul 2021 (T+90)
- 9,355 shares@ US$4.310.0% of flowCommon StockSEC:0001493152-21-004650:0Canonical exit: 23 May 2021 (T+90)
- 200 shares@ US$4.45Common StockSEC:0001493152-21-004650:1Canonical exit: 24 May 2021 (T+90)
- 6,000 shares@ US$1.4584Common StockSEC:0001181431-07-069220:0
- 5,000 shares@ US$1.25Common StockSEC:0001181431-07-069220:1
- 700 shares@ US$1.30Common StockSEC:0001181431-07-069220:2
- 5,000 shares@ US$0.6632Common StockSEC:0001181431-07-069220:3
- 4,000 shares@ US$0.7113Common StockSEC:0001181431-07-069220:4
- 20,000 shares@ US$1.37Common StockSEC:0001181431-07-065931:0
- 5,000 shares@ US$1.41Common StockSEC:0001181431-07-065931:1
- 10,000 shares@ US$1.35Common StockSEC:0001181431-07-063822:0
- 9,500 shares@ US$1.44Common StockSEC:0001181431-07-063822:1
- 10,000 shares@ US$1.40Common StockSEC:0001181431-07-063823:0
- 20,000 shares@ US$0.68Common StockSEC:0001181431-07-057344:0
- 12,500 shares@ US$0.535Common StockSEC:0001181431-07-007590:0
- 17,345 shares@ US$0.51Common StockSEC:0001181431-07-007590:1
- 16,310 shares@ US$0.46Common StockSEC:0001181431-07-007590:2
- 10,000 shares@ US$0.45Common StockSEC:0001181431-07-007590:3
- 2,833 shares@ US$0.60Common StockSEC:0001181431-06-070263:0Canonical exit: 18 Mar 2007 (T+90)
- 1,000 shares@ US$0.71Common StockSEC:0001181431-06-062204:0
- 1,500 shares@ US$0.71Common StockSEC:0001181431-06-061709:0
- 100,000 shares@ US$61,000.00Common StockSEC:0001181431-06-058356:0Canonical exit: 1 Jan 2007 (T+90)
25 of 47 declarations
About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. is a company focused on the health and pharmaceutical sector. It concentrates on developing innovative solutions to enhance patient health and well-being.
